Caricamento...
Terbutaline and the Prevention of Nocturnal Hypoglycemia in Type 1 Diabetes
OBJECTIVE—Bedtime administration of 5.0 mg of the β(2)-adrenergic agonist terbutaline prevents nocturnal hypoglycemia but causes morning hyperglycemia in type 1 diabetes. We tested the hypothesis that 2.5 mg terbutaline prevents nocturnal hypoglycemia without causing morning hyperglycemia. RESEARCH...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Diabetes Association
2008
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2584177/ https://ncbi.nlm.nih.gov/pubmed/18782903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc08-0520 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|